First Time Loading...
X

Xenon Pharmaceuticals Inc
NASDAQ:XENE

Watchlist Manager
Xenon Pharmaceuticals Inc
NASDAQ:XENE
Watchlist
Price: 43.58 USD -0.39% Market Closed
Updated: May 6, 2024

Xenon Pharmaceuticals Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Xenon Pharmaceuticals Inc
Cash from Operating Activities Peer Comparison

Comparables:
ZYME
RPTX
FUSN
AUPH
EDT

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
X
Xenon Pharmaceuticals Inc
NASDAQ:XENE
Cash from Operating Activities
-$145.3m
CAGR 3-Years
-45%
CAGR 5-Years
-33%
CAGR 10-Years
N/A
Zymeworks Inc
NYSE:ZYME
Cash from Operating Activities
-$118.3m
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Cash from Operating Activities
-$127.2m
CAGR 3-Years
-176%
CAGR 5-Years
-59%
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Cash from Operating Activities
-$81.8m
CAGR 3-Years
-40%
CAGR 5-Years
-53%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Cash from Operating Activities
-$33.5m
CAGR 3-Years
22%
CAGR 5-Years
8%
CAGR 10-Years
-22%
Spectral Medical Inc
TSX:EDT
Cash from Operating Activities
-CA$10.7m
CAGR 3-Years
-222%
CAGR 5-Years
-35%
CAGR 10-Years
-2%

See Also

What is Xenon Pharmaceuticals Inc's Cash from Operating Activities?
Cash from Operating Activities
-145.3m USD

Based on the financial report for Dec 31, 2023, Xenon Pharmaceuticals Inc's Cash from Operating Activities amounts to -145.3m USD.

What is Xenon Pharmaceuticals Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-33%

Over the last year, the Cash from Operating Activities growth was -48%. The average annual Cash from Operating Activities growth rates for Xenon Pharmaceuticals Inc have been -45% over the past three years , -33% over the past five years .